WOODSTOCK CORP - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.6%.

Quarter-by-quarter ownership
WOODSTOCK CORP ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$288,000
-8.3%
4,4430.0%0.06%
-11.3%
Q3 2015$314,000
-36.4%
4,4430.0%0.07%
-23.7%
Q2 2015$494,000
+17.9%
4,4430.0%0.09%
+19.2%
Q1 2015$419,000
-15.9%
4,4430.0%0.08%
-16.1%
Q4 2014$498,000
+82.4%
4,4430.0%0.09%
+75.5%
Q3 2014$273,0004,4430.05%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders